Pharma
Stay updated with the latest happenings in the pharmaceutical industry. Get insights into drug development, innovations, regulatory updates, and emerging trends. Discover the advancements shaping the future of healthcare. Explore the world of pharma with our comprehensive coverage at Pharmtales.com.
Outlook’s eye drug Lytenava fails to win FDA approval, despite positive trial
Outlook Therapeutics has been working on a reformulated version of Roche’s cancer drug Avastin for the treatment of certain eye ...
AstraZeneca’s Farxiga confident of its edge over Novo’s Wegovy in heart failure market
Novo Nordisk’s semaglutide and AstraZeneca’s Farxiga assuming the roles of formidable contenders. The arena is no longer confined to blood ...
Serina Therapeutics merges with struggling AgeX Therapeutics to go public and advance its Parkinson’s drug
AgeX Therapeutics, a biotech that has been facing financial difficulties and stalled preclinical programs for years, has finally found a ...
Another Phase 3 flop for FibroGen as DMD drug fails to improve mobility
FibroGen’s troubles continue to mount. The biotech announced its fourth phase 3 failure in four months after the market closed ...
Pfizer and BioNTech challenge Moderna’s mRNA vaccine patents in a bid to end monopoly
The legal battle between Moderna and its rivals Pfizer and BioNTech over the patents related to mRNA vaccine production is ...
Cencora: The new name of the pharma giant formerly known as AmerisourceBergen
After more than two decades of being known as AmerisourceBergen, the pharmaceutical services company has decided to rebrand itself as ...
Novo Nordisk acquires Embark Biotech for 15 million euros in obesity deal spree
Novo Nordisk has made another move to expand its obesity portfolio, acquiring Embark Biotech for 15 million euros ($16 million) ...
Tecentriq SC: A Swift Leap Forward in Cancer Treatment Receives Green Light
Roche has proudly unveiled that Tecentriq SC (atezolizumab) has received the stamp of approval from the Medicines and Healthcare products ...
Roche’s Evrysdi Illuminates Hope: EC Expands Approval for SMA Infants
To provide a brighter future for infants battling spinal muscular atrophy (SMA), Roche has unveiled a momentous development. The European ...
3M Reaches Historic Settlement: The Sound of Justice Rings Louder
3M, the manufacturing giant, has concluded a chapter that involved battling allegations of knowingly distributing defective earplugs to the US ...
Sandoz Acquires Mycamine, a Top Antifungal Drug, from Astellas
In the ever-evolving landscape of medical advancements, Sandoz emerges as a dominant force, orchestrating a strategic move that echoes across ...
Novartis Unveils Breakthrough Long-Term Data: Leqvio Sustains LDL-C Reduction Beyond Six Years in ESC 2023
In the world of medical innovation, where the quest to tame cardiovascular risk is a relentless endeavor, Novartis unfurls a ...
Activist Investors Renew Battle Against Biotech Pioneering Long COVID Treatment at AIM Immunotech
In the ever-shifting landscape of corporate battles, AIM Immunotech finds itself once again on the front lines, grappling with a ...
Bracing for Change: CMS Unveils Drug Price Negotiation Targets Amid Industry Backlash
The day that pharmaceutical manufacturers have been cautiously eyeing has finally dawned – Tuesday saw the grand revelation of the ...
Bristol Myers Squibb’s Bold Robotic Alliance with Cellares for Advanced CAR-T Production
In the realm of cutting-edge cell therapy, where innovation is the heartbeat and the promise of transformative treatments is the ...
Navigating the Maze of “Bad Cholesterol”: A Wake-Up Call for Heart Survivors
In the delicate realm of heart health, where knowledge often stands as a shield against future battles, a surprising chasm ...
FDA Grants Approval: Reblozyl’s Triumph Ushers in a New Dawn for Anemia Treatment
Bristol Myers Squibb has ushered in a breakthrough in the realm of medical advancements, announcing the FDA’s seal of approval ...
Navigating Peaks and Valleys: Novocure’s Tumor Treating Fields Unveil Divergent Outcomes
In the complex realm of medical breakthroughs, the journey from triumph to setback can be as unpredictable as it is ...
BridgeBio Exposes Phase 3 Acoramidis Insights, Mortality Figures
In the intricate dance of scientific exploration, BridgeBio has taken a resolute plunge into the depths of phase 3 acoramidis ...
Bayer Advances Parkinson’s Cell Therapy to Phase 2 Trial
A new horizon gleams for Bayer’s quest to conquer Parkinson’s disease through advanced cell therapy. In a significant revelation, the ...
Legal Engagements Amid Scientific Advancements: Alnylam’s Ongoing Interplay with Moderna
In the intricate choreography of the biopharmaceutical world, where innovation and intellectual property intertwine, a dramatic legal ballet unfolds. Alnylam, ...
FTC’s Legal Pas de Deux: A Pause in the Amgen-Horizon Acquisition
In the world of corporate clashes and strategic maneuvers, a legal ballet is unfolding, with the Federal Trade Commission (FTC) ...
Unveiling the Intricate Symphony: AstraZeneca’s Farxiga at the Heart of Cardiorenal Insights
In the heart of Amsterdam, amidst the captivating backdrop of the European Society of Cardiology (ESC) scientific sessions, AstraZeneca wielded ...
Abcam’s Harmonious Acquisition by Danaher Shaping the Future of Antibody Research
In the realm where science meets commerce, a symphony of strategy and innovation is playing out. Just two months since ...
A Symphony of Change: Moderna’s Second Serve at the US Open Celebrates Arthur Ashe’s Legacy
After paying homage to the iconic Billie Jean King in their previous year’s advertisement, this year’s rendition shines a spotlight ...
Discover the rare yet aggressive uterine sarcoma, its symptoms, causes, and treatments.
A cancer called uterine sarcoma develops in the uterus’s (the womb’s) muscle or other tissues. It is different from endometrial ...
Unveiling 2023’s Drug Approvals: Beyond Oncology Boundaries
In the ever-evolving realm of oncology of 2023 emerges as a pivotal era characterized by a wave of significant approvals ...
Uterine Cancer: What You Need to Know
The pear-shaped organ in the female pelvis where a baby develops during pregnancy, the uterus, is affected by uterine cancer. ...
Exploring Real-World Anticoagulant Transitions: Insights Unveiled at the European Society of Cardiology (ESC) Congress 2023
Amidst the vivid tapestry of medical advancements, a pivotal revelation has emerged from the collaborative efforts of the Bristol Myers ...
Amgen’s Groundbreaking Discovery: Unleashing the Potential of Olpasiran Beyond Expectations
In a revelation that promises to reshape the landscape of cardiovascular health, biotechnology giant Amgen has unveiled extraordinary findings from ...
